Presented by Dr. Kevin Ard, participants will learn about innovative approaches to HIV prevention using a status-neutral framework with information on telehealth for pre-exposure prophylaxis (PrEP), PrEP On Demand, and more. The webinar also provides the most recent information about how to implement long-acting injectable PrEP at health centers.
Learning Resources — Webinars filtered by Topic
What’s Next in PrEP?: New Strategies for Prevention
Just over 10 years ago, the first agent for HIV pre-exposure prophylaxis was approved in the United States. Since then, the landscape of PrEP has shifted, with approval of additional PrEP medications and growth of low-threshold PrEP delivery strategies, such as same-day PrEP. In this interactive webinar, participants will learn about new medications in the pipeline for PrEP and emerging PrEP delivery models.
- Filed under
- Pre-Exposure Prophylaxis (PrEP)
Financing PrEP in the Current Era
In this webinar, Dr. Kevin Ard discussed recent developments in the field of PrEP, such as licensure of long-acting injectable medication for HIV pre-exposure prophylaxis (PrEP), availability of a generic PrEP formulation, and concerns about the 340B program. These developments have led to questions about financing PrEP in 2023 and beyond. In this interactive session, experts on PrEP will discuss the current PrEP financing landscape and what may be in store for the future.
- Filed under
- Pre-Exposure Prophylaxis (PrEP)
Promoting Health Equity for Black Transgender MSM in HIV Prevention, Treatment, and Access
Join us for a fireside chat with Dr. Tonia Poteat, PhD, PA-C, MPH from the UNC Center for Health Equity Research and Deborah Dunn where they discuss the importance of promoting health equity for Black Trans MSM seeking HIV prevention, treatment or testing. Topics include, but are not limited to discussing the effects of racism, transphobia, and other risk factors that contribute to medical mistrust in the Black and Trans community, as well as, the unique sexual and reproductive health needs of Black Trans MSM.
HIV and Monkeypox
In this webinar, Dr. Kevin Ard will discuss monkeypox and HIV. In the 2022 global monkeypox outbreak, people with HIV represented approximately 40% of those with monkeypox. In this clinically-focused webinar, participants will learn up-to-date information about the epidemiology, manifestations, testing, treatment, and prevention of monkeypox, with a focus on care for those with or at risk for HIV.
- Filed under
- HIV/STI Treatment and Prevention
PrEP and Transgender Communities: Evidence Informed Practices
In this talk from the 2022 Advancing Excellence in Transgender Health Care Conference, Dr. Tonia Poteat discusses evidence-informed practices for PrEP and Transgender communities. By the end of this talk, you will be able to describe current and pipeline options for PrEP, have reviewed existing data on PrEP among transgender people, and identify gender-affirming practices for PrEP implementation.
HIV Care for Transgender and Gender Diverse People
In this talk from the 2022 Advancing Excellence in Transgender Health Care Conference, Dr. Kevin Ard discusses HIV care for Trans and Gender Diverse people. By the end of this talk, you will be able to summarize the epidemiology of HIV among transgender and gender diverse people in the United States, identify common antiretroviral treatment regimens with low potential to interact with gender- affirming hormone therapy, and describe a comprehensive model of HIV care for transgender and gender diverse people.
Innovative Models for HIV Prevention and Care
In this interactive webinar, participants will learn about novel approaches to HIV prevention and care, including status-neutral care paradigms, same-day pre-exposure prophylaxis (PrEP), and rapid antiretroviral start programs. The webinar will also provide up-to-date information about how to implement long-acting injectable PrEP at health centers.
Meningococcal Disease Outbreak among Men Who Have Sex with Men in Florida: Background, Response, and Vaccination Recommendations
This collaborative webinar with the Centers for Disease Control & Prevention will focus on the ongoing outbreak of serogroup C meningococcal disease in Florida, mostly among men who have sex with men. Experts will provide background on meningococcal disease, an overview of the outbreak and the related response, and recommendations for vaccination.
- Filed under
- HIV/STI Treatment and Prevention
Long-Acting Injectable PrEP for HIV: What Health Centers Need to Know
Long-acting injectable cabotegravir was approved for HIV pre-exposure prophylaxis in late 2021. In this interactive webinar, participants will learn about the effectiveness, advantages, and disadvantages of long-acting injectable cabotegravir as well as the clinical and programmatic steps to incorporate it into practice.
- Filed under
- Pre-Exposure Prophylaxis (PrEP)